201 related articles for article (PubMed ID: 28390992)
1. Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosa.
Sharma TP; Wiley LA; Whitmore SS; Anfinson KR; Cranston CM; Oppedal DJ; Daggett HT; Mullins RF; Tucker BA; Stone EM
Stem Cell Res; 2017 May; 21():58-70. PubMed ID: 28390992
[TBL] [Abstract][Full Text] [Related]
2. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
[TBL] [Abstract][Full Text] [Related]
3. Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis.
DeLuca AP; Whitmore SS; Barnes J; Sharma TP; Westfall TA; Scott CA; Weed MC; Wiley JS; Wiley LA; Johnston RM; Schnieders MJ; Lentz SR; Tucker BA; Mullins RF; Scheetz TE; Stone EM; Slusarski DC
Hum Mol Genet; 2016 Jan; 25(1):44-56. PubMed ID: 26494905
[TBL] [Abstract][Full Text] [Related]
4. Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.
Leong YC; Sowden JC
Adv Exp Med Biol; 2023; 1415():555-563. PubMed ID: 37440086
[TBL] [Abstract][Full Text] [Related]
5. Generation of Human Patient iPSC-derived Retinal Organoids to Model Retinitis Pigmentosa.
Ma C; Jin K; Jin ZB
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786611
[TBL] [Abstract][Full Text] [Related]
6. The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa.
Yoshida T; Ozawa Y; Suzuki K; Yuki K; Ohyama M; Akamatsu W; Matsuzaki Y; Shimmura S; Mitani K; Tsubota K; Okano H
Mol Brain; 2014 Jun; 7():45. PubMed ID: 24935155
[TBL] [Abstract][Full Text] [Related]
7. Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids.
Lane A; Jovanovic K; Shortall C; Ottaviani D; Panes AB; Schwarz N; Guarascio R; Hayes MJ; Palfi A; Chadderton N; Farrar GJ; Hardcastle AJ; Cheetham ME
Stem Cell Reports; 2020 Jul; 15(1):67-79. PubMed ID: 32531192
[TBL] [Abstract][Full Text] [Related]
8. CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoids.
Buck TM; Quinn PMJ; Pellissier LP; Mulder AA; Jongejan A; Lu X; Boon N; Koot D; Almushattat H; Arendzen CH; Vos RM; Bradley EJ; Freund C; Mikkers HMM; Boon CJF; Moerland PD; Baas F; Koster AJ; Neefjes J; Berlin I; Jost CR; Wijnholds J
Stem Cell Reports; 2023 Sep; 18(9):1793-1810. PubMed ID: 37541258
[TBL] [Abstract][Full Text] [Related]
9. Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities.
Guo Y; Wang P; Ma JH; Cui Z; Yu Q; Liu S; Xue Y; Zhu D; Cao J; Li Z; Tang S; Chen J
Front Cell Neurosci; 2019; 13():361. PubMed ID: 31481876
[TBL] [Abstract][Full Text] [Related]
10. Activation of autophagy reverses progressive and deleterious protein aggregation in PRPF31 patient-induced pluripotent stem cell-derived retinal pigment epithelium cells.
Georgiou M; Yang C; Atkinson R; Pan KT; Buskin A; Molina MM; Collin J; Al-Aama J; Goertler F; Ludwig SEJ; Davey T; Lührmann R; Nagaraja-Grellscheid S; Johnson CA; Ali R; Armstrong L; Korolchuk V; Urlaub H; Mozaffari-Jovin S; Lako M
Clin Transl Med; 2022 Mar; 12(3):e759. PubMed ID: 35297555
[TBL] [Abstract][Full Text] [Related]
11. Modeling retinitis pigmentosa through patient-derived retinal organoids.
Li YP; Deng WL; Jin ZB
STAR Protoc; 2021 Jun; 2(2):100438. PubMed ID: 33899019
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
13. Human retinal organoids harboring IMPG2 mutations exhibit a photoreceptor outer segment phenotype that models advanced retinitis pigmentosa.
Mayerl SJ; Bajgai S; Ludwig AL; Jager LD; Williams BN; Bacig C; Stoddard C; Sinha D; Philpot BD; Gamm DM
Stem Cell Reports; 2022 Nov; 17(11):2409-2420. PubMed ID: 36206764
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
[TBL] [Abstract][Full Text] [Related]
16. [Toward establishment of regenerative cell therapy for retinitis pigmentosa using iPS cell derived retinal sheet].
Akiba R; Matsuyama T; Takahashi M; Mandai M
Nihon Yakurigaku Zasshi; 2020; 155(2):93-98. PubMed ID: 32115485
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution.
Leong YC; Di Foggia V; Pramod H; Bitner-Glindzicz M; Patel A; Sowden JC
Stem Cell Reports; 2022 Nov; 17(11):2421-2437. PubMed ID: 36240775
[TBL] [Abstract][Full Text] [Related]
18. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
[TBL] [Abstract][Full Text] [Related]
19. Structural Variants Create New Topological-Associated Domains and Ectopic Retinal Enhancer-Gene Contact in Dominant Retinitis Pigmentosa.
de Bruijn SE; Fiorentino A; Ottaviani D; Fanucchi S; Melo US; Corral-Serrano JC; Mulders T; Georgiou M; Rivolta C; Pontikos N; Arno G; Roberts L; Greenberg J; Albert S; Gilissen C; Aben M; Rebello G; Mead S; Raymond FL; Corominas J; Smith CEL; Kremer H; Downes S; Black GC; Webster AR; Inglehearn CF; van den Born LI; Koenekoop RK; Michaelides M; Ramesar RS; Hoyng CB; Mundlos S; Mhlanga MM; Cremers FPM; Cheetham ME; Roosing S; Hardcastle AJ
Am J Hum Genet; 2020 Nov; 107(5):802-814. PubMed ID: 33022222
[TBL] [Abstract][Full Text] [Related]
20. Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.
Zhang X; Zhang D; Thompson JA; Chen SC; Huang Z; Jennings L; McLaren TL; Lamey TM; De Roach JN; Chen FK; McLenachan S
Mol Genet Genomic Med; 2021 Mar; 9(3):e1601. PubMed ID: 33497524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
